Chew, Phyllis <br/><br/>
Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Jun 2009 
 - 823-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.109.186619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antioxidants--administration & dosage<br/>Aorta, Abdominal--drug effects<br/>Aorta, Thoracic--drug effects<br/>Aortic Diseases--etiology<br/>Apolipoproteins E--deficiency<br/>Atherosclerosis--etiology<br/>Azoles--administration & dosage<br/>Cells, Cultured<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetic Angiopathies--etiology<br/>Endothelial Cells--drug effects<br/>Glutathione Peroxidase--deficiency<br/>Humans<br/>I-kappa B Kinase--metabolism<br/>Isoindoles<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Macrophages--drug effects<br/>Male<br/>Membrane Glycoproteins--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Muscle, Smooth, Vascular--drug effects<br/>NADPH Oxidase 2<br/>NADPH Oxidases--metabolism<br/>Organoselenium Compounds--administration & dosage<br/>Phenotype<br/>Phosphorylation<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--metabolism<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Tyrosine--analogs & derivatives<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Glutathione Peroxidase GPX1